Related references
Note: Only part of the references are listed.Tri-Allelic Haplotypes Determine and Differentiate Functionally Normal Allele CYP2D6*2 and Impaired Allele CYP2D6*41
Ulrich M. Zanger et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
CYP2D6 genotyping analysis and functional characterization of novel allelic variants in a Ni-Vanuatu and Kenyan population by assessing dextromethorphan O-demethylation activity
Evelyn Marie Gutierrez Rico et al.
DRUG METABOLISM AND PHARMACOKINETICS (2020)
Effects of 26 Recombinant CYP3A4 Variants on Brexpiprazole Metabolism
Bingbing Chen et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2020)
Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies
Toshiro Niwa et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)
Development and validation of a sensitive and specific LC-MS/MS cocktail assay for CYP450 enzymes: Application to study the effect of catechin on rat hepatic CYP activity
Van Nguyen et al.
BIOMEDICAL CHROMATOGRAPHY (2020)
Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three-Dimensional Spheroid Cultures of Primary Human Hepatocytes
Delilah F. G. Hendriks et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Heterologous expression of high-activity cytochrome P450 in mammalian cells
Masaki Kumondai et al.
SCIENTIFIC REPORTS (2020)
Functional characterization of 21 CYP3A4 variants on amiodarone metabolism in vitro
Cheng-Cheng Yang et al.
XENOBIOTICA (2019)
An optimized prediction framework to assess the functional impact of pharmacogenetic variants
Yitian Zhou et al.
PHARMACOGENOMICS JOURNAL (2019)
Four Major Channels Detected in the Cytochrome P450 3A4: A Step toward Understanding Its Multispecificity
Lydia Benkaidali et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Functional characterization of 27 CYP3A4 protein variants to metabolize regorafenib in vitro
Ying-Hui Li et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2019)
Characterization of Genetic Variation in CYP3A4 on the Metabolism of Cabozantinib in Vitro
Qian-meng Lin et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2019)
Enzymatic Activities of CYP3A4 Allelic Variants on Quinine 3-Hydroxylation In Vitro
Xiao-Yang Zhou et al.
FRONTIERS IN PHARMACOLOGY (2019)
Functional characterization of 27 CYP3A4 variants on macitentan metabolism in vitro
Ying-hui Li et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
Functional characteristics of CYP3A4 allelic variants on the metabolism of loperamide in vitro
Qian-Meng Lin et al.
INFECTION AND DRUG RESISTANCE (2019)
CYP3A4/5 Activity Probed with Testosterone and Midazolam: Correlation between Two Substrates at the Microsomal and Enzyme Levels
Kang Xiao et al.
MOLECULAR PHARMACEUTICS (2019)
Influence of donor liver CYP3A4*20 loss-of-function genotype on tacrolimus pharmacokinetics in transplanted patients
Miguel A. Gomez-Bravo et al.
PHARMACOGENETICS AND GENOMICS (2018)
Functional characterization of 9 CYP2A13 allelic variants by assessment of nicotine C-oxidation and coumarin 7-hydroxylation
Masaki Kumondai et al.
DRUG METABOLISM AND PHARMACOKINETICS (2018)
Functional characterization of 40 CYP2B6 allelic variants by assessing efavirenz 8-hydroxylation
Takashi Watanabe et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Functional characterization of 50 CYP2D6 allelic variants by assessing primaquine 5-hydroxylation
Takahiro Saito et al.
DRUG METABOLISM AND PHARMACOKINETICS (2018)
Role of Cytochrome P450 Enzymes in the Metabolic Activation of Tyrosine Kinase Inhibitors
Klarissa D. Jackson et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Integrating rare genetic variants into pharmacogenetic drug response predictions
Magnus Ingelman-Sundberg et al.
HUMAN GENOMICS (2018)
Functional Characterization of 22 CYP3A4 Protein Variants to Metabolize Ibrutinib In Vitro
Ren-ai Xu et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4
Irina F. Sevrioukova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Functional assessment of CYP3A4 allelic variants on lidocaine metabolism in vitro
Ping Fang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Genetic variation in human drug-related genes
Charlotta Pauline Irmgard Scharfe et al.
GENOME MEDICINE (2017)
Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects
Y. Zhou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
High-Level Production and Properties of the Cysteine-Depleted Cytochrome P450 3A4
Irina F. Sevrioukova
BIOCHEMISTRY (2017)
Genetic Polymorphisms and in Vitro Functional Characterization of CYP2C8, CYP2C9, and CYP2C19 Allelic Variants
Masahiro Hiratsuka
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)
Effects of Circular DNA Length on Transfection Efficiency by Electroporation into HeLa Cells
Benjamin D. Hornstein et al.
PLOS ONE (2016)
Genetic variation in the human cytochrome P450 supergene family
Kohei Fujikura et al.
PHARMACOGENETICS AND GENOMICS (2015)
Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals
Masao Nagasaki et al.
NATURE COMMUNICATIONS (2015)
Whole-Exome Sequencing Reveals Defective CYP3A4 Variants Predictive of Paclitaxel Dose-Limiting Neuropathy
Maria Apellaniz-Ruiz et al.
CLINICAL CANCER RESEARCH (2015)
miRNA-27b levels are associated with CYP3A activity in vitro and in vivo
Lena Ekstrom et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Identification and Characterization of a Defective CYP3A4 Genotype in a Kidney Transplant Patient With Severely Diminished Tacrolimus Clearance
A. N. Werk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy
Laure Elens et al.
PHARMACOGENOMICS (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
In Vitro Assessment of the Allelic Variants of Cytochrome P450
Masahiro Hiratsuka
DRUG METABOLISM AND PHARMACOKINETICS (2012)
An Expanded, Unified Substrate Recognition Site Map for Mammalian Cytochrome P450s: Analysis of Molecular Interactions Between 15 Mammalian CYP450 Isoforms and 868 Substratesc
Alexander Zawaira et al.
CURRENT DRUG METABOLISM (2011)
CYP3A4*16 and CYP3A4*18 Alleles Found in East Asians Exhibit Differential Catalytic Activities for Seven CYP3A4 Substrate Drugs
Keiko Maekawa et al.
DRUG METABOLISM AND DISPOSITION (2010)
Selection of Alternative CYP3A4 Probe Substrates for Clinical Drug Interaction Studies Using In Vitro Data and In Vivo Simulation
Robert S. Foti et al.
DRUG METABOLISM AND DISPOSITION (2010)
Different Enzyme Kinetics of Midazolam in Recombinant CYP3A4 Microsomes from Human and Insect Sources
Hege Christensen et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
MicroRNAs Regulate CYP3A4 Expression via Direct and Indirect Targeting
Yu-Zhuo Pan et al.
DRUG METABOLISM AND DISPOSITION (2009)
New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process
Shiew-Mei Huang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities
F Sakurai et al.
GENE THERAPY (2005)
New AMBER force field parameters of heme iron for cytochrome P450s determined by quantum chemical calculations of simplified models
A Oda et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Recombinant CYP3A4*17 is defective in metabolizing the hypertensive drug nifedipine, and the CYP3A4*17 allele may occur on the same chromosome as CYP3A5*3, representing a new putative defective CYP3A haplotype
SJ Lee et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Genetic contribution to variable human CYP3A-mediated metabolism
JK Lamba et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Common allelic variants of cytochrome P4503A4 and their prevalence in different populations
JK Lamba et al.
PHARMACOGENETICS (2002)
Identification and functional characterization of eight CYP3A4 protein variants
R Eiselt et al.
PHARMACOGENETICS (2001)
High-performance liquid chromatographic method for the determination of benzodiazepines in plasma or serum using the column-switching technique
A El Mahjoub et al.
JOURNAL OF CHROMATOGRAPHY B (2000)
Share Paper
